首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Global Mapping of Traditional Chinese Medicine into Bioactivity Space and Pathways Annotation Improves Mechanistic Understanding and Discovers Relationships between Therapeutic Action (Sub)classes
【2h】

Global Mapping of Traditional Chinese Medicine into Bioactivity Space and Pathways Annotation Improves Mechanistic Understanding and Discovers Relationships between Therapeutic Action (Sub)classes

机译:对中药在生物活性空间和途径注释中的全球映射提高了对机制的理解并发现了治疗作用(亚类)之间的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Traditional Chinese medicine (TCM) still needs more scientific rationale to be proven for it to be accepted further in the West. We are now in the position to propose computational hypotheses for the mode-of-actions (MOAs) of 45 TCM therapeutic action (sub)classes from in silico target prediction algorithms, whose target was later annotated with Kyoto Encyclopedia of Genes and Genomes pathway, and to discover the relationship between them by generating a hierarchical clustering. The results of 10,749 TCM compounds showed 183 enriched targets and 99 enriched pathways from Estimation Score ≤ 0 and ≥ 5% of compounds/targets in a (sub)class. The MOA of a (sub)class was established from supporting literature. Overall, the most frequent top three enriched targets/pathways were immune-related targets such as tyrosine-protein phosphatase nonreceptor type 2 (PTPN2) and digestive system such as mineral absorption. We found two major protein families, G-protein coupled receptor (GPCR), and protein kinase family contributed to the diversity of the bioactivity space, while digestive system was consistently annotated pathway motif, which agreed with the important treatment principle of TCM, “the foundation of acquired constitution” that includes spleen and stomach. In short, the TCM (sub)classes, in many cases share similar targets/pathways despite having different indications.
机译:中医(TCM)仍然需要更多的科学依据来证明其在西方得到进一步的接受。我们现在可以根据计算机靶标预测算法为45种TCM治疗作用(子)类的作用模式(MOA)提出计算假设,该靶标随后用《京都议定书》的基因和基因组途径注释,并通过生成层次聚类来发现它们之间的关系。 10,749种中药化合物的结果表明,(子)类别中估计得分≤0和5%的化合物/目标化合物中有183种富集目标和99种富集途径。 (子)类的MOA是根据支持文献建立的。总体而言,最常见的前三个富集目标/途径是与免疫相关的目标,例如酪氨酸蛋白磷酸酶非受体2型(PTPN2)和消化系统,例如矿物质吸收。我们发现两个主要的蛋白家族,即G蛋白偶联受体(GPCR)和蛋白激酶家族,促进了生物活性空间的多样性,而消化系统始终被注释为途径基序,这与中医的重要治疗原则相符。获得性体质的基础”,包括脾胃。简而言之,尽管有不同的指示,但在许多情况下,TCM(子)类具有相似的目标/途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号